Teprotumumab-trbw (Tepezza; Amgen) has demonstrated clinical benefit in thyroid eye disease (TED), but less is known about ...
In the latest episode of The Retina TL;DR with Dr. Weng—Part 2 of a special two-part series—host Christina Y. Weng, MD, MBA, ...
October 16, 2026, delivered 3 ophthalmic FDA approvals that, taken together, touch nearly every corner of the eye care ...
Docking the trailing haptic is the step where surgeons most often struggle with the Yamane technique, according to Murtaza K.
Omur Ucakhan, MD, explains why artificial tears are not interchangeable and how dry eye phenotype should guide formulation ...
The epidemiology, inflammatory pathophysiology, diagnosis, and treatment of diabetic macular edema are discussed during ...
At AAO 2026, Anjum F. Koreishi, MD, shared how to prevent complications after cataract surgery in patients with uveitis.
Eleonora Lad, MD, PhD, Dimitra Skondra, MD, PhD, and John Kitchens, MD, point to structure and function, diet and the gut, ...
Jacque Duncan, MD, reviews phase 3 DRAGON data on oral tinlarebant for Stargardt disease and its mechanism-related visual ...
Timothy Janetos, MD, explained when to refer uveitis to a specialist and why access to uveitis care remains limited.
LUCIA, the second of 2 pivotal phase 3 trials in neovascular (wet) age-related macular degeneration (AMD), missed its primary ...
A study published in JAMA Ophthalmology 1 reported that spectacle lenses with highly aspherical lenslets (HAL) are safe and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results